{"nctId":"NCT00542178","briefTitle":"Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)","startDateStruct":{"date":"2003-10"},"conditions":["Diabetic Retinopathy"],"count":3472,"armGroups":[{"label":"Intensive glycemia control","type":"EXPERIMENTAL","interventionNames":["Drug: Hypoglycemic Agents"]},{"label":"Standard glycemia control","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Standard glycemia control"]},{"label":"Intensive BP control","type":"EXPERIMENTAL","interventionNames":["Drug: Intensive BP treatment"]},{"label":"Standard BP control","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Standard BP control"]},{"label":"Fibrate","type":"EXPERIMENTAL","interventionNames":["Drug: Fenofibrate","Drug: Simvastatin"]},{"label":"Fibrate Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Simvastatin","Drug: Placebo"]}],"interventions":[{"name":"Hypoglycemic Agents","otherNames":[]},{"name":"Standard glycemia control","otherNames":[]},{"name":"Intensive BP treatment","otherNames":[]},{"name":"Standard BP control","otherNames":[]},{"name":"Fenofibrate","otherNames":[]},{"name":"Simvastatin","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Participating in the ACCORD study\n\nExclusion Criteria:\n\n* Has had laser photocoagulation for DR\n* Has had vitrectomy surgery for DR","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","maximumAge":"79 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Progression of Diabetic Retinopathy of at Least 3 Stages on the Early Treatment Diabetic Retinopathy Study (ETDRS) Scale, or Development of Proliferative Diabetic Retinopathy Necessitating Photocoagulation Therapy or Vitrectomy","description":"Diabetic retinopathy status was defined according to the eye with the highest level on the ETDRS Final Severity Scale for Persons, as follows: no diabetic retinopathy, a level of less than 20; mild diabetic retinopathy, a level of 20; moderate nonproliferative diabetic retinopathy (NPDR), a level above 20 but less than 53; severe diabetic retinopathy, a level of 53 but less than 60; and proliferative diabetic retinopathy (PDR), a level of 60 or higher.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"104","spread":null},{"groupId":"OG001","value":"149","spread":null},{"groupId":"OG002","value":"67","spread":null},{"groupId":"OG003","value":"54","spread":null},{"groupId":"OG004","value":"52","spread":null},{"groupId":"OG005","value":"80","spread":null}]}]}]},{"type":"SECONDARY","title":"Loss of Visual Acuity","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"744","spread":null},{"groupId":"OG001","value":"752","spread":null},{"groupId":"OG002","value":"367","spread":null},{"groupId":"OG003","value":"382","spread":null},{"groupId":"OG004","value":"354","spread":null},{"groupId":"OG005","value":"393","spread":null}]}]}]},{"type":"SECONDARY","title":"Cataract Extraction","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"547","spread":null},{"groupId":"OG001","value":"623","spread":null},{"groupId":"OG002","value":"266","spread":null},{"groupId":"OG003","value":"300","spread":null},{"groupId":"OG004","value":"305","spread":null},{"groupId":"OG005","value":"299","spread":null}]}]}]},{"type":"SECONDARY","title":"Development or Progression of Macular Edema","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"44","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"18","spread":null},{"groupId":"OG003","value":"20","spread":null},{"groupId":"OG004","value":"24","spread":null},{"groupId":"OG005","value":"22","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}}